POSTER LIBRARY

Use the links below to download posters from our international meetings.

Click here to learn more about the poster presentation submission process.

Fall Summit 2024

Adjuvant Ribociclib Plus Nonsteroidal Aromatase Inhibitor in Patients with HR+_HER2- Early Breast Cancer_4-Year Outcomes from the NATALEE Trial

Aligning with NCCN_A Comparative Analysis of Digital Tools for Adult Carboplatin Dosing

An Analysis of Ruxolitinib Dosing for Myelofibrosis in Real-World Practice

Baseline characteristics and efficacy endpoints for patients with node-negative HR+_HER2- early breast cancer in NATALEE

Building a New Oral Anti-Cancer Medication Nurse Navigation Program

CMS STAR Medication Adherence Overview

Descriptive analysis of hepatic safety in patients with HR+_HER2- breast cancer treated with ribociclib + endocrine therapy

Development of Stimuli-responsive Nanocarrier for Prostate Cancer Treatment

Efficacy of Pacritinib in Patients with myelofibrosis who Have Both Thrombocytopenia and Anemia

Evaluating the First Nationwide Canadian Oncology Mentorship Program (2022-2023) by the University of Toronto NCODA Chapter

Factors that may Influence Physicians’ Perceptions of Cure in Ovarian Cancer_A Discrete Choice Experiment

Glofitamab plus Gemcitabine and Oxaliplatin (Glofit-GemOx) for Relapsed-Refractory (R_R) Diffuse Large B-cell Lymphoma (DLBCL)_Results of a Global Randomized Phase III Trial (STARGLO)

Long Covid and Liver Injury AKA PASC: Post Acute Sequelae of SARS-CoV-2 (COVID-19) Infection

Loratinib versus Crizotinib in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer_5-Year Outcomes from the Phase III CROWN Study

Medically Integrated Specialty Pharmacy Optimization of Adherence and Persistence for Renal Cell Carcinoma Tyrosine Kinase Inhibitors

Medication Assistance Renewal Process Optimization at an Integrated Health System Specialty Pharmacy

Nanotechnology Innovations & New Cancer Treatments

NATALEE update-safety and treatment duration of ribociclib + nonsteroidal aromatase inhibitor in patients with HR+_HER2- early breast cancer

Navigating Financial Assistance Programs for Oncology Patients

Pharmacist Tailored Monitoring for patients Initiating Encorafenib and Binimetinib Combination Therapy

Pharmacist-Led Monitoring for Patients Initiating PARP Inhibitor Therapy

Pharmacists Impact on Managing Drug-Drug Interactions with Venetoclax in a Medically-Integrated Specialty Pharmacy

Pilot Student-Led Patient Education and Proactive Toxicities Follow-Up for Moderately and Highly Emetogenic Chemotherapy Regimens at an Outpatient Oncology Clinic in New Brunswick

Real-world risk of recurrence among patients diagnosed with stage II-III HR+/HER2- early breast cancer treated with endocrine therapy in the US

Real-World Treatment Patterns and Effectiveness in Patients with ALK+ Advanced NSCLC Treated with 1L ALK TKIs

Real-World Treatment Patterns and Outcomes in Patients with Myelofibrosis Treated with Pacritinib in the United States

Review of Digital Twin Modeling Strategies in Medicine: Methodological Approaches, Applications, and Emerging Trends

Role of Ibrutinib in management of CNS involvement with chronic lymphoproliferative disorders: Case Study and Review of Literature (Updated from two years ago)

Safe Storage and Disposal of Oral and Topical Oncolytics

Short-term risk of recurrence in patients with HR+/HER2- early breast cancer treated with endocrine therapy in randomized clinical trials: a meta-analysis

Statin Use and its influence on Survival Outcomes in Patients with Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Streamlining Pharmacy Services: The Impact of Decentralized Pharmacy Technicians

Supporting Oncology Patients Through Medication Prior Authorizations and Appeals

Talking Blood Counts, Treatment Goals, and Health Equity in Myelofibrosis: Findings from a Patient Advocacy Group Consensus Panel

The Impact in Quality of Life of Adverse Events with Systemic Therapies for Metastatic Colorectal Cancer Previously Treated with Standard Therapies and Biologics in the United States

The NCODA Nursing Community: Where Collaboration and Innovation Cultivate Excellence in Oncology Care

The Real-World Value of Medically Integrated Dispensing

The Role of Oncology Pharmacy Technicians to Address Health Disparities

The role of SRBT (stereotactic body radiotherapy) for intrahepatic cholangiocarcinoma recurrence after liver transplantation

Thorough QT Analysis of a Single Dose of Pacritinib: Results of the PAC107 Study

Treatment of a JAK1 Positive Chronic Eosinophilic Leukemia with JAK 1/2 Inhibitor Ruxolitinib

Use of Bispecific T-Cell Engaging Antibodies (BsAbs) in Community Practices: Multidisciplinary Perspectives on Developing Logistics and Workflow for Cytokine Release Syndrome (CRS) Management

Spring Forum 2024

A Multimodality Approach to Addressing New Drug Approvals

Addressing Barriers to Identifying HER2-Low Metastatic Breast Cancer Patients in a Large Community Oncology Practice

Administration of Ibrutinib Oral Suspension Via Nasogastric and Gastrostomy Tubes

ALINA: Efficacy and Safety of Adjuvant Alectinib Versus Chemotherapy in Patients with Early-Stage ALK+ non-Small Cell Lung Cancer (NSCLC)

Becoming an Oncology Certified Pharmacy Technician- Oncology Pharmacy Technician Certification Program

Budget Impact of Selinexor Combination Regimens in Previously Treated Multiple Myeloma: An Oncology Network Perspective

Cancer Repository

Driving Speed-to-Medication Access

Evaluating Socioeconomic Status, Racial, and US Geographic Regional Differences in Biomarker Testing and Treatment in Advanced Ovarian Cancer

Early Identification for Fertility Preservation Improves Referrals in a Community Oncology Practice

Efficacy and Safety of First-Line Ribociclib + Letrozole in Patients with De Novo Metastatic Disease and Late Recurrence from (neo) Adjuvant Therapy in MONALEESA-2

Efficacy and Safety of Trifluridine/Tipiracilin Combination with Bevacizumab in Older and Younger Patients with Refractory Metastatic Colorectal Cancer: A Subgroup Analysis of the Phase 3 SUNLIGHT Trial

First-line Ribociclib + Endocrine Therapy vs Combination Chemotherapy in Aggressive HR+/HER2− Advanced Breast Cancer: A Subgroup Analysis of Patients With or Without Visceral Crisis From the Phase II RIGHT Choice Study

Health Advocates- Holistically Weaving Together Strategies That Illuminate The Path Toward Better Patient Outcomes

Hepatitis B Screening Practices in the Setting of Immunotherapy-Related Adverse Events

Impact of a Best Practices Program in Patients with Relapsed Refractory Multiple Myeloma Receiving Selinexor

Impact of Clinical Competency on the Prior Authorization Process

Impact of Nirogacestat on Functional Status in Patients with Desmoid Tumors: Results From the Phase 3 DeFi Study

Impact of Nursing in Preventing Patient Delays When Receiving Free Drug from the Manufacturer

KontRASt-01 Update Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)

Launching a Centralized Financial Assistance Team – Increasing Medication Access

Leading The Next Generation of Oncology Professionals

Making a Difference in Your Community: NCODA’s Partnership with NMDP

Medically Integrated Dispensing- A Technicians Perspective

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool: An Online Method of Identifying and Preventing Drug Waste

Neurokinin-1 Antagonist Therapy Optimization Through a Systematic Approach at the University of New Mexico Comprehensive Cancer Center

Ocular Adverse Events (OAEs) in Newer Chemotherapeutic Agents: An Overview of Clinical Presentation and Management Strategies

Oncology Nurse Navigator Use of Clinical Decision Support Pathways to Support Remote Symptom Management (RSM) of Oncology Patients

Oncology Pharmacy Technician Association (OPTA)

Oral Oncology Risk Evaluation & Mitigation Strategies (REMS)

Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice

Patient Preferences for CDK4 6 Inhibitor Treatments in HR+ HER2− Early Breast Cancer- A Discrete Choice Survey Study

Platelet Response in Pacritinib-Treated Patients with Cytopenic Myelofibrosis: a Retrospective Analysis of PERSIST-2 and PAC203 Studies

Proactive Site of Care Evaluation for IVIG Infusion: Transition in Cancer Care Patients to Home Infusion

Readability of Online Patient and Physician Education Materials for Blood Cancer Diagnoses

Reclassification of ASCERTAIN (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) based on IPSS-R and IPSS-M Scoring Systems

Retrospective Analysis of the Relationship between Transfusion Independence and Bone Marrow Fibrosis Reduction in Patients with Myelofibrosis Treated with Pacritinib versus Ruxolitinib

Ribociclib + Nonsteroidal Aromatase Inhibitor as Adjuvant Treatment in Patients With HR+ HER2− Early Breast Cancer- Final Invasive Disease–Free Survival Analysis From the NATALEE Trial

Selinexor Dose Optimization

Selinexor Dose Optimization Retrospective Analysis

Starting an Interprofessional PSO Chapter as a Distance Student

The NCODA Nursing Community- Where Collaboration and Innovation Cultivate Excellence in Oncology Care

Utilization of Positive Quality Interventions and Treatment Support Kits with Decitabine and Cedazurdine

XS004 Dasatinib (XS004) Improves Variability and Bioavailability in Humans Using Amorphous Solid Dispersion Formulation of Dasatinib with Implications for Its Clinical Use

Fall Summit 2023

2023-2024 Medicare Part D Coverage Update

A Real-World Comparative Effectiveness Analysis of Fostamatinib VS. Thrombopoietin Receptor Agonists (PTOs) for Treatment of Chronic Immune Thrombocytopenia in Adult Patients

Ajufo_SOHO2023_Landmark OS SVR

Biodistribution and Shedding Analysis Following Treatment with RP1 Oncolytic Immunotherapy in the Skin Cancer Patients from the IGNYTE Clinical Trial

Cancer Health Disparities- Addressing Unmet Screening Needs in a Community Cancer Clinic

Carboplatin Case Study on Impact of Oncology Drug Shortages

Cause of Death and Prognosis of Patients With Primary Refractory Disease, and Prognosis of Patients Reaching PFS24

Comparison of Discontinuation Rates in Patients Receiving an Oral Anticancer Agent Before and After Implementation of a 14 day Pharmacist Checkin Protocol

Concordance Between Solid Tissue and Liquid Biopsy for Gene Mutations in Advanced Cancer Patients- Single Center Study

Corganics Clinical CBD

Current Status and Future Perspectives of Precision Oncology in Greece

Development and Characterization of Bigels for Topical Applications

Drug Shortage Management in Community Oncology- Ensuring Access to Vital Medications

Efficacy of Pacritinib for Spleen, Symptoms, and Anemia Benefit in Myelofibrosis Patients Across the Cytopenic Spectrum

Ellagic Acid Induces Apoptosis in Neuroblastoma via Multiple Signaling Pathways

Empowering Cancer Patients- Reducing Financial Barriers through Pharmacist-Led Counseling (NOLA Initiative Case Study)

Enhancing Immunotherapy Efficacy with the Use of Antihistamines in Cancer Patients-A Review of Published Studies

Evaluating the Impact of Continuous Infusion Chemotherapy Titration Protocol on Administration Time and Length of Stay in Inpatient Oncology Unit

Exploring the Impact of Dietary Factors on Colorectal Cancer- A Review of Published Research

Final Prespecified Overall Survival Analysis of CLEAR- 4-Year Follow-Up of Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma

Financial Impact of Integrated Specialty Pharmacy Efforts to Avoid Oral Oncolytic Waste

Futibatinib in Patients With FGFR2-Rearranged Intrahepatic Cholangiocarcinoma- Responder Analyses of Efficacy and Safety From the Phase 2 FOENIX-CCA2 Study

Glofitamab in Patients With Relapsed Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies

Growth of NCODA Professional Student Organization Chapters

Health-Related Quality of Life Associated with Trifluridine:tipiracil in Combination with Bevacizumab in Refractory Metastatic Colorectal Cancer- An Analysis of the Phase III SUNLIGHT Trial

Identification of Practitioner Needs when Caring for Patients Taking Oral Anticancer Medications

Impact of Nirogacestat on Pain, a Key Symptom in Patients With Desmoid Tumors- Results From the Phase 3 DeFi Study

Increasing Accessibility for Hispanic Cancer Patients

Independent Health Advocacy

Initial Efficacy and Safety Results from ENGOT-ov60 GOG-3052 RAMP 201

Legislative and Policy Advisory Committee (LPAC)

Letermovir for Cytomegalovirus Prophylaxis in Patients Post Hematopoietic Stem Cell Transplant

Maintained ECOG-PS with Trifluridine-tipiracil in Combination with Bevacizumab in Refractory Metastatic Colorectal Cancer- An Analysis of the Phase III SUNLIGHT Trial

Managing Medication Inventory as a Pharmacy Technician

Maximizing Cost Savings – The Impact of Specialty Pharmacist Interventions at a Community Oncology Center

Medically Integrated Pharmacy – Enhancing the Patient Experience

Mosunetuzumab Monotherapy Demonstrates Durable Efficacy With a Manageable Safety Profile in Patients With Relapsed Refractory Follicular Lymphoma Who Received ≥2 Prior Therapies

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool – An Online Method of Identifying and Preventing Drug Waste

Navigating Diagnostic Challenges – Hemophagocytic Lymphohistiocytosis (HLH) in the Context of Sepsis and Cancer Management

NCODA 2023 RAMP 201 Part A Encore

NCODA Nursing Community

NCODA Positive Quality Interventions (PQI)

NCODA PQI Smoking Cessation

NCODA Webinar Series

NCODA, Expanding Oncology Care to Uganda and Africa

Non-Pharmacological Management of Anxiety in Cancer Patients

Nursing Education Series Led by the Specialty Pharmacy Team

Oncology Pharmacy Technician Association (OPTA)

Optimizing Venous Thromboembolism Prophylaxis in Cancer Patients- A Retrospective Study Based on Khorana Score Assessment and Anticoagulation Prescriptions

Outcomes of Patients with Myelofibrosis and Elevated Peripheral Blood Blasts Treated with Pacritinib on Phase 2:3 Trials

Patient Assistance Made A Top Priority

Patients’ Perspectives on Oral Decitabine and Cedazuridine for the Treatment of Myelodysplastic Syndromes

Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFR TKI and Platinum-Based Chemotherapy- HERTHENA-Lung01

PFAS Contamination and Cancer – An Emerging Concern

Poly (ADP-RIBOSE) Polymerase Inhibitor (PARPi) Therapy. Retrospective Analysis of Adverse Events and Treatment Modifications During the First 90 Days of Therapy

Providing Proactive Care for Patients Taking Oral Oncolytics to Minimize Adverse Reactions and Optimize Adherence

Regulatory Approval of Oncolytic Biosimilars- A Comparative Analysis of Alymsys and Zirabev

Risk of Severe Toxicity from Topical Fluoropyrimidine Treatment in Patients Carrying DPYD Variant Alleles

RSV In Immunocompromised Patients

Student Impact on Quality Improvement Initiative- IMiD Therapy Adherence Assessment

System-Wide Collaborative Oncology Nurse Navigation

Teamwork in Healthcare

The Life Cycle of an Oral Oncolytic in the MID – IOD Setting

The Role of Erythropoietin Stimulating Agents (ESAs) in the Treatment Landscape of Myelodysplastic Syndrome (MDS)

The Role of Guideline Directed Medical Therapy in Trastuzumab Induced Heart Failure and Cardiotoxicity

The Role of SBRT in Recurrence in Liver Post Liver Transplant Patient (cholangiocarcinoma) – A Case Report of Cholangiocarcinoma – One of the Rarest and Longest Ever Reported Case Study

The Value Of Oncology Trained Nurses in a Medically Integrated Pharmacy Continuing the Cancer Care Continuum, Maximizing Cost Avoidance and Reducing Waste of Oral Oncolytic Medications

Treatment Support Kits (TSK)

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

contact@ncoda.org

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization